Global Cord Blood Gross Profit

Global Cord Blood (CO) currently reports a gross profit of $1B as of July 2022. That compares with $1B in the prior-year period — up 3.7% year over year. That is below the Healthcare sector average of $65B. Use the charts on this page to explore Global Cord Blood's gross profit history and peer comparisons.

Global Cord Blood's gross profit increased from $1B to $1B — a 3.7% year-over-year increase (period ending July 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Global Cord Blood's gross profit of $1B is lower than the Healthcare sector average of $65B. That is roughly 98.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Global Cord Blood reported $1B in gross profit as of July 2022. That compares with $1B in the prior-year period — up 3.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $1B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $65B. From there, open related valuation or income-statement pages for Global Cord Blood, and consider following CO for alerts when major investors trade the stock.